Pharmacoepidemiology Research-Real-World Evidence for Decision Making.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial.Journal of the National Cancer Institute · 2024
   Trial
2. Performance of active drug safety monitoring and management for pharmacovigilance strengthening in Ethiopia, experience from a multidrug-resistant tuberculosis management program: a cross-sectional study.BMJ open · 2026
   Article
3. AI-Powered Drug Classification and Indication Mapping for Pharmacoepidemiologic Studies: Prompt Development and Validation.JMIR AI · 2025
   Article
4. Linking Electronic Health Record Prescribing Data and Pharmacy Dispensing Records to Identify Patient-Level Factors Associated With Psychotropic Medication Receipt: Retrospective Study.JMIR medical informatics · 2025
   Article
5. Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies.Frontiers in pharmacology · 2024
   Article
6. Pharmacoepidemiology: An Overview.Journal of clinical medicine · 2023
   Review
7. Perspectives on deprescribing in palliative care.Expert review of clinical pharmacology · 2023
   Review
8. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.Frontiers in cellular and infection microbiology · 2023
   Article
9. Experiences and Perspectives of Marketing Authorisation Holders towards Medication Safety Monitoring during Pregnancy: A Pan-European Qualitative Analysis.International journal of environmental research and public health · 2022
   Article
10. Generating fit-for-purpose real-world evidence in Asia: How far are we from closing the gaps?Perspectives in clinical research
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as